CLINICAL ROLE -
Etanercept and Ustekinumab Dosing for Psoriasis and Psoriatic Arthritis
For patients with psoriasis and/or psoriatic arthritis, actual-to-expected dosing ratios and costs were lower for etanercept than for ustekinumab.
Compliance and Cost of Biologic Therapies for Rheumatoid Arthritis
Medication compliance is associated with lower overall and disease-related healthcare costs in patients with moderate to severe rheumatoid arthritis receiving biologic therapies.
Effectiveness and Costs of Biologics in Veterans With Rheumatoid Arthritis
This study applied a validated algorithm to estimate the effectiveness and costs of the index biologic used by 4696 US veterans with rheumatoid arthritis.
Comparative Effectiveness of TNF Blockers in Rheumatoid Arthritis Patients
Among rheumatoid arthritis patients newly treated with adalimumab, etanercept, or infliximab, lower dose escalation rates and costs were seen with etanercept.
2 Clarke Drive Cranbury, NJ 08512